|
Volumn 5 Suppl 1, Issue , 1998, Pages
|
Multisite study of the safety and efficacy of LumenHance, a new gastrointestinal contrast agent for MRI of the abdomen and pelvis.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETIC ACID;
CONTRAST MEDIUM;
DIAGNOSTIC AGENT;
GLYCINE;
MANGANESE CHLORIDE;
MANGANESE DERIVATIVE;
PECTIN;
SUCROSE;
ABDOMEN;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
DRUG TOLERANCE;
FEMALE;
HISTOLOGY;
HUMAN;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PELVIS;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
SAFETY;
ABDOMEN;
CONTRAST MEDIA;
DRUG COMBINATIONS;
DRUG TOLERANCE;
FEMALE;
GLYCINE;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MALE;
MANGANESE COMPOUNDS;
MIDDLE AGED;
PECTINS;
PELVIS;
SAFETY;
SODIUM ACETATE;
SUCROSE;
MLCS;
MLOWN;
|
EID: 0032042384
PISSN: 10766332
EISSN: None
Source Type: Journal
DOI: 10.1016/s1076-6332(98)80087-1 Document Type: Article |
Times cited : (7)
|
References (0)
|